Poh Hwa Ooi1, Sandra Thompson-Hodgetts2, Lesley Pritchard-Wiart3, Susan M Gilmour4,5, Diana R Mager1,4. 1. Department of Agricultural, Food & Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada. 2. Department of Occupational Therapy, University of Alberta, Edmonton, Alberta, Canada. 3. Department of Physical Therapy, University of Alberta, Edmonton, Alberta, Canada. 4. Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. 5. Division of Pediatric Gastroenterology & Nutrition/Transplant Services, The Stollery Children's Hospital, Alberta Health Services, Edmonton, Alberta, Canada.
Abstract
BACKGROUND: Malnutrition is a common complication in children with chronic diseases. Sarcopenia is one component of malnutrition, characterized by reduced skeletal muscle mass (SMM) and muscle function. The presence of sarcopenia is associated with adverse outcomes in children. Although there is growing research interest in sarcopenia, no review has been done on this novel concept in pediatrics. The purpose of this review was to explore current evidence in sarcopenia with and without obesity and to evaluate the knowledge gaps in the assessment of childhood sarcopenia. METHODS: A total of 12 articles retrieved from PubMed or Web of Science databases were included. RESULTS: Limited studies have elucidated sarcopenia in pediatrics. Challenges in sarcopenia assessment include heterogeneity in definition and absence of standardized body composition methods used to measure SMM and muscle function tests. There is a lack of age-specific and gender-specific normative data for SMM, particularly in young children and infants. None of the studies incorporated muscle function assessment, causing potential bias and misclassification of sarcopenia. The research in childhood sarcopenia is also hampered by low study quality, limited number of outcomes-based research, and lack of longitudinal data. CONCLUSION: Consensus needs to be reached in methodological approaches in sarcopenia diagnosis, body composition measurements, and age-appropriate muscle function tests in pediatrics. Careful considerations on growth, neurocognitive status, and factors influencing development in various clinical populations are warranted. Early identification of sarcopenia is crucial to enable targeted treatment and prevention to be carried out across the pediatric clinical populations.
BACKGROUND: Malnutrition is a common complication in children with chronic diseases. Sarcopenia is one component of malnutrition, characterized by reduced skeletal muscle mass (SMM) and muscle function. The presence of sarcopenia is associated with adverse outcomes in children. Although there is growing research interest in sarcopenia, no review has been done on this novel concept in pediatrics. The purpose of this review was to explore current evidence in sarcopenia with and without obesity and to evaluate the knowledge gaps in the assessment of childhood sarcopenia. METHODS: A total of 12 articles retrieved from PubMed or Web of Science databases were included. RESULTS: Limited studies have elucidated sarcopenia in pediatrics. Challenges in sarcopenia assessment include heterogeneity in definition and absence of standardized body composition methods used to measure SMM and muscle function tests. There is a lack of age-specific and gender-specific normative data for SMM, particularly in young children and infants. None of the studies incorporated muscle function assessment, causing potential bias and misclassification of sarcopenia. The research in childhood sarcopenia is also hampered by low study quality, limited number of outcomes-based research, and lack of longitudinal data. CONCLUSION: Consensus needs to be reached in methodological approaches in sarcopenia diagnosis, body composition measurements, and age-appropriate muscle function tests in pediatrics. Careful considerations on growth, neurocognitive status, and factors influencing development in various clinical populations are warranted. Early identification of sarcopenia is crucial to enable targeted treatment and prevention to be carried out across the pediatric clinical populations.
Authors: Nguyen K Tram; Ting-Heng Chou; Laila N Ettefagh; Kyra Deep; Adam J Bobbey; Anthony N Audino; Mitchel R Stacy Journal: Eur Radiol Date: 2022-08-10 Impact factor: 7.034
Authors: Antoinette A Amevor; Toshifumi Yodoshi; Andrew T Trout; Jonathan R Dillman; Ruchi Singh; Ryan Jarvis; Lin Fei; Chunyan Liu; Amy Taylor; Alexander Miethke; Marialena Mouzaki Journal: Liver Int Date: 2021-11-29 Impact factor: 8.754
Authors: Emma Jacobine Verwaaijen; Annelienke van Hulst; Marta Fiocco; Annelies Hartman; Martha Grootenhuis; Saskia Pluijm; Rob Pieters; Erica van den Akker; Marry M van den Heuvel-Eibrink Journal: JMIR Res Protoc Date: 2022-04-11
Authors: Wagner Luis Ripka; Camila E Orsso; Andrea M Haqq; Thais Gretis Luz; Carla M Prado; Leandra Ulbricht Journal: PLoS One Date: 2020-02-06 Impact factor: 3.240
Authors: Ryan McGrath; Kyle J Hackney; Nicholas A Ratamess; Brenda M Vincent; Brian C Clark; William J Kraemer Journal: Adv Geriatr Med Res Date: 2019-12-31
Authors: Carla M Prado; Stefan D Anker; Andrew J S Coats; Alessandro Laviano; Stephan von Haehling Journal: J Cachexia Sarcopenia Muscle Date: 2020-12-31 Impact factor: 12.910
Authors: Jennifer C Lai; Puneeta Tandon; William Bernal; Elliot B Tapper; Udeme Ekong; Srinivasan Dasarathy; Elizabeth J Carey Journal: Hepatology Date: 2021-09 Impact factor: 17.298